In the latest quarter, 15 analysts provided ratings for KKR KKR, showcasing a mix of bullish and bearish perspectives.
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 6 | 8 | 1 | 0 | 0 |
| Last 30D | 0 | 0 | 1 | 0 | 0 |
| 1M Ago | 1 | 0 | 0 | 0 | 0 |
| 2M Ago | 4 | 5 | 0 | 0 | 0 |
| 3M Ago | 1 | 3 | 0 | 0 | 0 |
Analysts have set 12-month price targets for KKR, revealing an average target of $135.87, a high estimate of $154.00, and a low estimate of $116.00. This upward trend is evident, with the current average reflecting a 9.1% increase from the previous average price target of $124.54.
Decoding Analyst Ratings: A Detailed Look
The analysis of recent analyst actions sheds light on the perception of KKR by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| Michael Brown | Wells Fargo | Announces | Equal-Weight | $130.00 | - |
| Nicholas Watts | Redburn Atlantic | Announces | Buy | $153.00 | - |
| Chris Allen | Citigroup | Raises | Buy | $150.00 | $130.00 |
| Devin Ryan | JMP Securities | Raises | Market Outperform | $135.00 | $115.00 |
| Bill Katz | TD Cowen | Raises | Buy | $154.00 | $145.00 |
| Alexander Blostein | Goldman Sachs | Raises | Buy | $137.00 | $123.00 |
| Benjamin Budish | Barclays | Raises | Overweight | $146.00 | $117.00 |
| Chris Kotowski | Oppenheimer | Raises | Outperform | $128.00 | $121.00 |
| Kyle Voigt | Keefe, Bruyette & Woods | Raises | Outperform | $144.00 | $125.00 |
| Brian Bedell | Deutsche Bank | Raises | Buy | $141.00 | $128.00 |
| Glenn Schorr | Evercore ISI Group | Raises | Outperform | $117.00 | $112.00 |
| Kyle Voigt | Keefe, Bruyette & Woods | Raises | Outperform | $125.00 | $116.00 |
| Benjamin Budish | Barclays | Raises | Overweight | $117.00 | $114.00 |
| Bill Katz | TD Cowen | Lowers | Buy | $145.00 | $157.00 |
| Kyle Voigt | Keefe, Bruyette & Woods | Maintains | Outperform | $116.00 | $116.00 |
Key Insights:
- Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to KKR. This insight gives a snapshot of analysts' perspectives on the current state of the company.
- Rating: Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of KKR compared to the broader market.
- Price Targets: Analysts predict movements in price targets, offering estimates for KKR's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of KKR's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
Stay up to date on KKR analyst ratings.
Discovering KKR: A Closer Look
KKR is one of the world's largest alternative asset managers, with $601.3 billion in total managed assets, including $487.3 billion in fee-earning AUM, at the end of June 2024. The company has two core segments: asset management (which includes private markets—private equity, credit, infrastructure, energy, and real estate—and public markets—primarily credit and hedge/investment fund platforms) and insurance (following the firm's initial investment in, and then ultimate purchase of, Global Atlantic Financial Group, which is engaged in retirement/annuity and life insurance lines as well as reinsurance).
Key Indicators: KKR's Financial Health
Market Capitalization Analysis: With an elevated market capitalization, the company stands out above industry averages, showcasing substantial size and market acknowledgment.
Positive Revenue Trend: Examining KKR's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 14.54% as of 30 June, 2024, showcasing a substantial increase in top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Financials sector.
Net Margin: KKR's net margin is below industry standards, pointing towards difficulties in achieving strong profitability. With a net margin of 16.26%, the company may encounter challenges in effective cost control.
Return on Equity (ROE): KKR's ROE is below industry averages, indicating potential challenges in efficiently utilizing equity capital. With an ROE of 3.1%, the company may face hurdles in achieving optimal financial returns.
Return on Assets (ROA): KKR's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of 0.19%, the company may encounter challenges in delivering satisfactory returns from its assets.
Debt Management: KKR's debt-to-equity ratio is notably higher than the industry average. With a ratio of 2.32, the company relies more heavily on borrowed funds, indicating a higher level of financial risk.
Understanding the Relevance of Analyst Ratings
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
